纯化大麻二醇的治疗潜力
Saoirse Elizabeth O'Sullivan1, Sanne Skov Jensen2, Gitte Nykjaer Nikolajsen2
1CanPharmaConsulting, Nottingham, NG9 3BB, UK. canpharmaconsulting@gmail.com.
Journal of cannabis research
|June 13, 2023
概括
大麻 (CBD) 显示出超越的治疗潜力,有证据支持其用于焦虑,精神病,创伤后应激障碍和药物滥用. 需要进一步的大规模试验来确认在各种条件下有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床治疗学 临床治疗学
- 大麻素研究 研究 大麻素研究
背景情况:
- Cannabidiol (CBD) 正在获得治疗应用的关注.
- 现有研究因某些CBD产品中存在THC等其他植物化学物质而复杂化.
- 只有纯化CBD (Epidiolex) 是FDA批准用于特定的疾病.
研究的目的:
- 批判性地审查使用仅纯化CBD产品的临床研究.
- 为了确定净化CBD的潜在未来指示.
- 为了区分纯化CBD与混合大麻素产品的证据.
主要方法:
- 对专注于纯化CBD的临床研究进行系统审查.
- 分析来自无控研究和随机对照试验 (RCT) 的数据.
- 排除涉及混合大麻素配方的研究.
主要成果:
- 最强有力的证据支持CBD治疗焦虑,精神病/精神分裂症,PTSD和药物滥用.
- 对于睡眠质量,帕金森病,自闭症,戒烟,移植对宿主疾病和肠道透性也存在积极的数据.
- 目前的RCT证据不支持CBD治疗疼痛,COVID-19症状,癌症,亨廷顿病或2型糖尿病.
结论:
- 已发表的临床证据支持纯化CBD用于以外的多种适应症.
- 证据基础受限于专注于急性影响,健康志愿者或小患者数量的研究.
- 需要进行大规模的第三期证实性试验,以验证所有潜在的适应症的疗效.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
327
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
327
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
272
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
272
Therapeutic Index
4.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.4K
Analgesia and Pain Management
668
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
668
Dose-Response Relationship: Potency and Efficacy
4.6K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K


